Short Interest in Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Drops By 50.0%

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) saw a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 800 shares, a decrease of 50.0% from the February 13th total of 1,600 shares. Based on an average daily volume of 559,900 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are short sold.

Daiichi Sankyo Stock Up 0.1 %

Daiichi Sankyo stock traded up $0.02 during trading hours on Friday, hitting $23.75. The stock had a trading volume of 269,155 shares, compared to its average volume of 236,834. The stock’s 50-day moving average price is $25.42 and its 200-day moving average price is $30.06. The stock has a market capitalization of $45.32 billion and a P/E ratio of 27.62. Daiichi Sankyo has a 12-month low of $22.47 and a 12-month high of $42.48. The company has a quick ratio of 2.11, a current ratio of 2.77 and a debt-to-equity ratio of 0.06.

Daiichi Sankyo (OTCMKTS:DSNKY) last released its quarterly earnings data on Friday, January 31st. The company reported $0.22 EPS for the quarter. Daiichi Sankyo had a return on equity of 14.53% and a net margin of 13.62%. Equities research analysts anticipate that Daiichi Sankyo will post 0.73 EPS for the current fiscal year.

About Daiichi Sankyo

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.